Who Benefits From Immunotherapy?
Success of immune checkpoint inhibitors in clinical trials does not always carry over to patients in the clinic.
Home > Patients, Caregivers, and Advocates > Research > Who Benefits From Immunotherapy?
Success of immune checkpoint inhibitors in clinical trials does not always carry over to patients in the clinic.
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now